| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium/calmodulin-dependent protein kinase activity | 2.11e-05 | 27 | 40 | 3 | GO:0004683 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | 2.42e-04 | 446 | 40 | 6 | GO:0004674 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 4.63e-04 | 938 | 40 | 8 | GO:0016772 | |
| GeneOntologyMolecularFunction | calcium-dependent cysteine-type endopeptidase activity | 5.22e-04 | 17 | 40 | 2 | GO:0004198 | |
| GeneOntologyMolecularFunction | protein kinase activity | 1.15e-03 | 600 | 40 | 6 | GO:0004672 | |
| GeneOntologyMolecularFunction | exopeptidase activity | 1.39e-03 | 110 | 40 | 3 | GO:0008238 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 2.36e-03 | 36 | 40 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | 2.69e-03 | 709 | 40 | 6 | GO:0016773 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 3.20e-03 | 42 | 40 | 2 | GO:0044390 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 3.35e-03 | 43 | 40 | 2 | GO:0008307 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 3.35e-03 | 43 | 40 | 2 | GO:0004177 | |
| GeneOntologyMolecularFunction | kinase activity | 3.89e-03 | 764 | 40 | 6 | GO:0016301 | |
| GeneOntologyCellularComponent | calpain complex | 2.14e-05 | 4 | 40 | 2 | GO:0110158 | |
| GeneOntologyCellularComponent | caspase complex | 1.59e-04 | 10 | 40 | 2 | GO:0008303 | |
| Domain | GOLD_2 | 4.47e-06 | 2 | 40 | 2 | PF13897 | |
| Domain | Calpain_III | 2.91e-04 | 12 | 40 | 2 | IPR022683 | |
| Domain | calpain_III | 2.91e-04 | 12 | 40 | 2 | SM00720 | |
| Domain | C2_III | 2.91e-04 | 12 | 40 | 2 | IPR033883 | |
| Domain | Calpain_domain_III | 3.44e-04 | 13 | 40 | 2 | IPR022682 | |
| Domain | Calpain_III | 3.44e-04 | 13 | 40 | 2 | PF01067 | |
| Domain | Calpain_cysteine_protease | 4.00e-04 | 14 | 40 | 2 | IPR022684 | |
| Domain | CysPc | 4.61e-04 | 15 | 40 | 2 | SM00230 | |
| Domain | CALPAIN_CAT | 4.61e-04 | 15 | 40 | 2 | PS50203 | |
| Domain | Peptidase_C2_calpain_cat | 4.61e-04 | 15 | 40 | 2 | IPR001300 | |
| Domain | EMP24_GP25L | 4.61e-04 | 15 | 40 | 2 | PF01105 | |
| Domain | Peptidase_C2 | 4.61e-04 | 15 | 40 | 2 | PF00648 | |
| Domain | GOLD_dom | 7.47e-04 | 19 | 40 | 2 | IPR009038 | |
| Domain | GOLD | 7.47e-04 | 19 | 40 | 2 | PS50866 | |
| Domain | THIOL_PROTEASE_CYS | 1.41e-03 | 26 | 40 | 2 | PS00139 | |
| Domain | THIOL_PROTEASE_ASN | 1.52e-03 | 27 | 40 | 2 | PS00640 | |
| Domain | THIOL_PROTEASE_HIS | 1.52e-03 | 27 | 40 | 2 | PS00639 | |
| Domain | Pept_cys_AS | 1.63e-03 | 28 | 40 | 2 | IPR000169 | |
| Domain | EF-hand_8 | 2.40e-03 | 34 | 40 | 2 | PF13833 | |
| Domain | S_TKc | 7.11e-03 | 359 | 40 | 4 | SM00220 | |
| Domain | Ig_I-set | 7.77e-03 | 190 | 40 | 3 | IPR013098 | |
| Domain | I-set | 7.77e-03 | 190 | 40 | 3 | PF07679 | |
| Domain | Pkinase | 8.73e-03 | 381 | 40 | 4 | PF00069 | |
| Domain | Ca/CaM-dep_Ca-dep_prot_Kinase | 9.58e-03 | 69 | 40 | 2 | IPR020636 | |
| Domain | IG | 1.23e-02 | 421 | 40 | 4 | SM00409 | |
| Domain | Ig_sub | 1.23e-02 | 421 | 40 | 4 | IPR003599 | |
| Domain | Ank | 1.27e-02 | 228 | 40 | 3 | PF00023 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22140070 | ||
| Pubmed | [Expression of calpain 1 and calpain 2 during the skin incised wound healing in mice]. | 1.29e-06 | 2 | 40 | 2 | 17619446 | |
| Pubmed | Calpain 1 and 2 are required for RNA replication of echovirus 1. | 1.29e-06 | 2 | 40 | 2 | 18032503 | |
| Pubmed | Calpain-2 participates in the process of calpain-1 inactivation. | 1.29e-06 | 2 | 40 | 2 | 33078830 | |
| Pubmed | Cloning of m-calpain 80 kD subunit from the axonal degeneration-resistant WLD(S) mouse mutant. | 1.29e-06 | 2 | 40 | 2 | 9669314 | |
| Pubmed | Vitamin D₃ regulation of body fat, cytokines, and calpain gene expression. | 1.29e-06 | 2 | 40 | 2 | 25520983 | |
| Pubmed | Calpain activation contributes to hyperglycaemia-induced apoptosis in cardiomyocytes. | 1.29e-06 | 2 | 40 | 2 | 19505932 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15471877 | ||
| Pubmed | m-Calpain is required for preimplantation embryonic development in mice. | 1.29e-06 | 2 | 40 | 2 | 16433929 | |
| Pubmed | Calpains are required for invasive and metastatic potentials of human HCC cells. | 1.29e-06 | 2 | 40 | 2 | 23733271 | |
| Pubmed | Involvement of calpains in growth factor-mediated migration. | 1.29e-06 | 2 | 40 | 2 | 16971167 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 29258546 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 28594313 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22335024 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27622212 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 19781581 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 27185592 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 22432027 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 17359359 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 30177812 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 20193680 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 14980313 | ||
| Pubmed | Inhibition of calpain stabilises podosomes and impairs dendritic cell motility. | 1.29e-06 | 2 | 40 | 2 | 16723743 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 24285894 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 15302874 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 30177525 | ||
| Pubmed | The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation. | 3.87e-06 | 3 | 40 | 2 | 28924170 | |
| Pubmed | Expression and immunolocalization of the calpain-calpastatin system in the human oocyte. | 3.87e-06 | 3 | 40 | 2 | 15950654 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 19318376 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 23977256 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21839844 | ||
| Pubmed | Extracellular Calpain/Calpastatin Balance Is Involved in the Progression of Pulmonary Hypertension. | 3.87e-06 | 3 | 40 | 2 | 26974350 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 21415394 | ||
| Pubmed | LOX-1 in macrophage migration in response to ox-LDL and the involvement of calpains. | 3.87e-06 | 3 | 40 | 2 | 26393906 | |
| Pubmed | Calpain-generated natural protein fragments as short-lived substrates of the N-end rule pathway. | 3.87e-06 | 3 | 40 | 2 | 24550490 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 28334907 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 18840650 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 19683220 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 8954122 | ||
| Pubmed | The novel benzimidazole derivative, MPTB, induces cell apoptosis in human chondrosarcoma cells. | 3.87e-06 | 3 | 40 | 2 | 21374734 | |
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 16361262 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 10830966 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 16598790 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 16632474 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 3038169 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 23536090 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 27456359 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 32017927 | ||
| Pubmed | Characterization of the calcium-dependent proteolytic system in a mouse muscle cell line. | 7.73e-06 | 4 | 40 | 2 | 11952156 | |
| Pubmed | Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. | 7.73e-06 | 4 | 40 | 2 | 16998475 | |
| Pubmed | 17-Beta-estradiol increases neuronal excitability through MAP kinase-induced calpain activation. | 7.73e-06 | 4 | 40 | 2 | 19995977 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 12634108 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 9407132 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 8738748 | ||
| Pubmed | Calpain: novel family members, activation, and physiologic function. | 7.73e-06 | 4 | 40 | 2 | 8561910 | |
| Pubmed | Four genes for the calpain family locate on four distinct human chromosomes. | 7.73e-06 | 4 | 40 | 2 | 2209092 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 35606145 | ||
| Pubmed | The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway. | 7.73e-06 | 4 | 40 | 2 | 27453531 | |
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 26966280 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 22555453 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 10825211 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 22064597 | ||
| Pubmed | Calpain translocation during muscle fiber necrosis and regeneration in dystrophin-deficient mice. | 1.29e-05 | 5 | 40 | 2 | 8806430 | |
| Pubmed | Calpain II colocalizes with detergent-insoluble rafts on human and Jurkat T-cells. | 1.29e-05 | 5 | 40 | 2 | 12150984 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 21836084 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 17646163 | ||
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 20041182 | ||
| Pubmed | Ionomycin-activated calpain triggers apoptosis. A probable role for Bcl-2 family members. | 1.29e-05 | 5 | 40 | 2 | 12000759 | |
| Pubmed | 1.29e-05 | 5 | 40 | 2 | 17897354 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 1.83e-05 | 1353 | 40 | 9 | 29467282 | |
| Pubmed | Association of the calpain/calpastatin network with subcellular organelles. | 1.93e-05 | 6 | 40 | 2 | 14559243 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 16530191 | ||
| Pubmed | Dicer cleavage by calpain determines platelet microRNA levels and function in diabetes. | 2.70e-05 | 7 | 40 | 2 | 25944670 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 9396712 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 20962236 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | 3.24e-05 | 1455 | 40 | 9 | 22863883 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 9473662 | ||
| Pubmed | 4.62e-05 | 9 | 40 | 2 | 10978167 | ||
| Pubmed | Vital role of the calpain-calpastatin system for placental-integrity-dependent embryonic survival. | 8.45e-05 | 12 | 40 | 2 | 21791606 | |
| Pubmed | 8.45e-05 | 12 | 40 | 2 | 2899541 | ||
| Pubmed | 2.30e-04 | 103 | 40 | 3 | 32744500 | ||
| Pubmed | 3.21e-04 | 23 | 40 | 2 | 26124079 | ||
| Pubmed | Novel raf kinase protein-protein interactions found by an exhaustive yeast two-hybrid analysis. | 3.21e-04 | 23 | 40 | 2 | 12620389 | |
| Pubmed | 3.34e-04 | 1168 | 40 | 7 | 19946888 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 5.19e-04 | 1257 | 40 | 7 | 36526897 | |
| Pubmed | 6.26e-04 | 32 | 40 | 2 | 36278411 | ||
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | 6.39e-04 | 931 | 40 | 6 | 27432908 | |
| Pubmed | 6.61e-04 | 613 | 40 | 5 | 22268729 | ||
| Pubmed | 6.66e-04 | 33 | 40 | 2 | 36964131 | ||
| Pubmed | 7.32e-04 | 153 | 40 | 3 | 10718198 | ||
| Pubmed | In Vitro Reconstitution and Analysis of SARS-CoV-2/Host Protein-Protein Interactions. | 9.79e-04 | 40 | 40 | 2 | 37483225 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | 1.01e-03 | 1016 | 40 | 6 | 19056867 | |
| Pubmed | 1.03e-03 | 390 | 40 | 4 | 17643375 | ||
| Interaction | TINAGL1 interactions | 1.04e-06 | 39 | 40 | 4 | int:TINAGL1 | |
| Interaction | GNS interactions | 7.08e-06 | 136 | 40 | 5 | int:GNS | |
| GeneFamily | C2 domain containing|Calpains | 1.91e-04 | 15 | 25 | 2 | 975 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.38e-03 | 161 | 25 | 3 | 593 | |
| GeneFamily | Ankyrin repeat domain containing | 4.38e-03 | 242 | 25 | 3 | 403 | |
| GeneFamily | Fibronectin type III domain containing | 2.04e-02 | 160 | 25 | 2 | 555 | |
| Coexpression | GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN | 1.27e-05 | 199 | 40 | 5 | M7443 | |
| Coexpression | GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP | 1.30e-05 | 200 | 40 | 5 | M9299 | |
| Drug | SNJ-1945 | 1.09e-06 | 12 | 40 | 3 | CID006857712 | |
| Drug | p-MeC | 1.80e-06 | 14 | 40 | 3 | CID000451929 | |
| Drug | nitridochromium | 3.01e-06 | 2 | 40 | 2 | CID000090362 | |
| Drug | creatinine | 1.36e-05 | 302 | 40 | 6 | CID000000588 | |
| Drug | Triamcinolone [124-94-7]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 2.26e-05 | 195 | 40 | 5 | 2241_DN | |
| Drug | e BW | 3.74e-05 | 37 | 40 | 3 | CID000001338 | |
| Disease | hereditary spastic paraplegia 76 (implicated_via_orthology) | 1.70e-05 | 5 | 39 | 2 | DOID:0110821 (implicated_via_orthology) | |
| Disease | sex interaction measurement, ulcerative colitis | 2.29e-04 | 17 | 39 | 2 | EFO_0000729, EFO_0008343 | |
| Disease | Nephritis, Tubulointerstitial | 3.52e-04 | 21 | 39 | 2 | C0041349 | |
| Disease | Nephritis, Interstitial | 4.61e-04 | 24 | 39 | 2 | C0027707 | |
| Disease | traumatic brain injury (biomarker_via_orthology) | 4.61e-04 | 24 | 39 | 2 | DOID:0081292 (biomarker_via_orthology) | |
| Disease | Glycogen Storage Disease | 5.85e-04 | 27 | 39 | 2 | C0017919 | |
| Disease | sporadic amyotrophic lateral sclerosis | 8.43e-04 | 140 | 39 | 3 | EFO_0001357 | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 1.04e-03 | 36 | 39 | 2 | DOID:11723 (implicated_via_orthology) | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 1.49e-03 | 43 | 39 | 2 | DOID:2476 (implicated_via_orthology) | |
| Disease | Hypertensive disease | 2.03e-03 | 190 | 39 | 3 | C0020538 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CLEWFYEYAGTDDVV | 106 | Q92564 | |
| WGLDDVDYLFSEEDY | 141 | Q8TDI0 | |
| DPVEDFRYIWGGFAY | 596 | P78363 | |
| DWEYLGFASPEEYAE | 751 | Q9P2G1 | |
| YYDIDAQTFADWGVD | 151 | P06280 | |
| EWETVVGDDFSLYYD | 261 | Q96KQ7 | |
| TGEELGFDYGDRFWD | 1146 | Q96KQ7 | |
| SEGFEDFTGGVTEWY | 211 | P07384 | |
| YFEGGVSSVYLWDLD | 111 | P47756 | |
| WFEGEILQDGEDYQY | 616 | Q0ZGT2 | |
| LAESELSGWDYEYGF | 321 | P22888 | |
| DEDYYGSAAEWGDEA | 11 | Q8IXH7 | |
| FDRSGFVFDYEYDWA | 316 | P78368 | |
| GLQDFDELYDWEYEG | 601 | Q8N6G6 | |
| GYYIVHYEDDGWDSL | 606 | Q9NZ08 | |
| DPYEEWSYSDFFSED | 1186 | P50748 | |
| GQLYFEEGWYEEALE | 66 | Q9P2M1 | |
| EEGSYLFWEFATDNY | 411 | Q9H3P7 | |
| LFWEFATDNYDIGFG | 416 | Q9H3P7 | |
| ATDNYDIGFGVYFEW | 421 | Q9H3P7 | |
| YGYTTDDIEFYWRGD | 181 | P47870 | |
| GDLWSYDFFSGEFVV | 276 | O15297 | |
| IKEGYYEFESPFWDD | 231 | Q96NX5 | |
| GYGFKQEYESFFEGW | 891 | Q92729 | |
| IVFGDYTWTEFDEPF | 51 | Q15645 | |
| DDGSDAGWEEYFDYI | 791 | Q9BZJ0 | |
| AGWEEYFDYIFPEDA | 796 | Q9BZJ0 | |
| LAGDYEFDSPYWDDI | 241 | Q8NCB2 | |
| DYWRGDYEVNGVDGY | 201 | Q9BYF1 | |
| EWGLQEGQDPFFYDY | 141 | Q9P2S6 | |
| DYVANGGWETFLSYE | 426 | Q9H9T3 | |
| YPDLSFWDTEEAYIG | 1186 | Q9Y4K1 | |
| DEWGDNYFLVGPYTE | 56 | P13807 | |
| TEGFEDFTGGIAEWY | 201 | P17655 | |
| IFFYTGNEGDVWAFA | 71 | Q9UHL4 | |
| YWTAVFEYEAAGEDE | 56 | P80192 | |
| FWTYFIIDGVFSGDA | 331 | P46019 | |
| FYVAGRDWDDFGVTE | 146 | Q6IEE7 | |
| LEYQWFVDFAVYSGG | 101 | Q9NX61 | |
| DWDGELYENGSFYFA | 206 | Q8NFW8 | |
| DEYWRSTEYGEGYAC | 181 | P07911 | |
| AGYGDGYDDWETDED | 401 | Q12899 | |
| WEFATDDYDIGFGVY | 206 | Q6PL24 | |
| DDYDIGFGVYFDWTP | 211 | Q6PL24 | |
| GYFVDFREEDAGEWI | 846 | P54296 |